CLINICAL_TRIALS
trial_result
· 2019-05-14
Clinical Trial Update: Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of milnacipran in pediatric patients with primary fibromyalgia; study terminated with posted results in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Primary Fibromyalgia | Phase 2 | Status: TERMINATED | Results posted: 2019-05-14